DaVita HealthCare Partners Inc. (NYSE:DVA)‘s stock had its “buy” rating reiterated by analysts at Jefferies Group in a research note issued on Saturday. They presently have a $70.00 price target on the stock, down from their previous price target of $86.00. Jefferies Group’s price objective suggests a potential upside of 13.78% from the company’s previous close.

DVA has been the subject of a number of other research reports. Wells Fargo & Co. restated an “outperform” rating on shares of DaVita HealthCare Partners in a report on Tuesday, November 1st. Zacks Investment Research upgraded DaVita HealthCare Partners from a “strong sell” rating to a “hold” rating in a report on Friday, November 4th. Bank of America Corp. cut DaVita HealthCare Partners from a “buy” rating to a “neutral” rating and set a $70.00 price objective for the company. in a report on Tuesday, September 6th. Raymond James Financial Inc. upgraded DaVita HealthCare Partners from a “market perform” rating to an “outperform” rating and set a $75.00 price objective for the company in a report on Tuesday, September 20th. Finally, Citigroup Inc. started coverage on DaVita HealthCare Partners in a report on Tuesday, September 6th. They set a “neutral” rating and a $71.00 price objective for the company. Nine investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $74.58.

Analyst Recommendations for DaVita HealthCare Partners (NYSE:DVA)

Shares of DaVita HealthCare Partners (NYSE:DVA) traded down 0.76% during trading on Friday, hitting $61.52. The stock had a trading volume of 3,764,862 shares. The company has a market cap of $12.14 billion, a P/E ratio of 17.93 and a beta of 1.00. DaVita HealthCare Partners has a 12 month low of $54.50 and a 12 month high of $78.77. The stock has a 50-day moving average price of $61.43 and a 200 day moving average price of $70.18.

DaVita HealthCare Partners (NYSE:DVA) last posted its quarterly earnings data on Wednesday, November 2nd. The company reported $0.95 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.93 by $0.02. DaVita HealthCare Partners had a return on equity of 16.16% and a net margin of 4.92%. The company earned $3.73 billion during the quarter, compared to analysts’ expectations of $3.72 billion. During the same quarter in the previous year, the business earned $1.12 EPS. DaVita HealthCare Partners’s revenue was up 5.8% compared to the same quarter last year. Equities analysts expect that DaVita HealthCare Partners will post $3.78 EPS for the current fiscal year.

A number of hedge funds and other institutional investors have recently made changes to their positions in DVA. Piedmont Investment Advisors LLC acquired a new position in shares of DaVita HealthCare Partners during the third quarter valued at about $295,000. Peloton Wealth Strategists acquired a new position in shares of DaVita HealthCare Partners during the third quarter valued at about $1,302,000. Xact Kapitalforvaltning AB acquired a new position in shares of DaVita HealthCare Partners during the third quarter valued at about $947,000. Green Square Capital LLC acquired a new position in shares of DaVita HealthCare Partners during the third quarter valued at about $264,000. Finally, Advantus Capital Management Inc raised its position in shares of DaVita HealthCare Partners by 2.4% in the third quarter. Advantus Capital Management Inc now owns 16,406 shares of the company’s stock valued at $1,084,000 after buying an additional 388 shares in the last quarter. 83.10% of the stock is currently owned by institutional investors.

DaVita HealthCare Partners Company Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, is a provider of kidney care services. The Company operates Kidney Care division and HealthCare Partners (HCP) division. The Company’s segments include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives.

5 Day Chart for NYSE:DVA

Receive News & Stock Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related stocks with our FREE daily email newsletter.